NRSN
NeuroSense Therapeutics Ltd. Ordinary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
NRSN Stock Analysis: Buy, Sell, or Hold?
$1.79
+0.01 (+0.69%)
▲
5d:
+28.47%
30d:
-41.43%
90d:
+295.54%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
56/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.71 – $3.37
Position: SLIGHTLY LOW
Forward P/E & Valuation
-0.4x
Next 12M consensus est.
Wall Street Target
$91.75
+5054.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.10 / $2.22
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: NRSN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When NRSN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NRSN is currently trading at $1.79, which is considered slightly low relative to its 30-day fair value range of $1.71 to $3.37.
Technical Outlook: Technically, NRSN is in a uptrend. Immediate support is located at $1.10, while resistance sits at $2.22.
Market Sentiment: NRSN scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $91.75 (+5054.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NRSN is in a uptrend. Immediate support is located at $1.10, while resistance sits at $2.22.
Market Sentiment: NRSN scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $91.75 (+5054.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.71 -
$3.37
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$1.71 -
$3.37
Current vs Trading Range
SLIGHTLY LOW
Support Level
$1.10
Resistance Level
$2.22
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 5054.5% below Wall St target ($91.75)
- CAUTION: Bottoming setup, but lagging the sector by 34% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
-0.38
Wall Street Target
$91.75
(+5054.5%)
Share NRSN Analysis
Share this live NRSN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NRSN)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits disclosed purchasing $NRSN shares at an average cost of $1.45, with a target price of $5.
Key Retail Themes:
buy
target price
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:06 PM ET
Data refreshes hourly during market hours. Next update: 4:06 PM
Data refreshes hourly during market hours. Next update: 4:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRSN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NRSN Research Pages
